Skip to main content
UniHealth

Doctor search

Eman Bahrani, MD

Dermatology · Nashville

NPI 1073963997

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
3
1 carrier
Office
1
Since medical school
10 years
Baylor College of Medicine, 2016

Offices

1 location · Vanderbilt University Medical Center · 3,510 clinicians in this group

Looking this up.

Hospitals listed: Vanderbilt University Medical Center. That is not proof they admit you there this week.

Plans that list them

3 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bahrani’s office at (615) 322-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A152474 · Delinquent

Licence status: Delinquent · since 2017 · expires 2023-11-30 · Baylor College of Medicine.

License renewal fee has not been paid. No practice is permitted.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Tennessee 66159Medical Doctor · since 2022 · expires 2027-11-30Specialty on the licence: Dermatology; Dermatopathology
    LicensedNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

3 placements

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Education

  • Baylor College of Medicine · MDHouston, TX · 2016Medical school

Residency and fellowship

  • Fellowship, DermatopathologyPalo Alto, CA · 2020–2021
  • Residency, DermatologySan Francisco, CA · 2017–2020
  • Internship, Internal MedicineCambridge, MA · 2016–2017

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Vanderbilt University Medical CenterNashville, TNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Vanderbilt Health, which runs 4 hospitalsHome of Vanderbilt-Ingram Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.28 (2.41 to 4.15) · 6,585 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.2 (0.85 to 1.54) · 15,700 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.591, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.703, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,175 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Vanderbilt University Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Vanderbilt University Medical Center
Postoperative hemorrhage or hematoma rateComplications and deaths3.28 (2.41 to 4.15) · 6,585 casesWorseJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths1.2 (0.85 to 1.54) · 15,700 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.591BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.703BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,175 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.21 (0.56 to 1.87) · 4,737 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.13 (0.97 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.72 (117.43 to 174.02) · 459 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.8 · 228 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths9.6 · 135 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.1 · 223 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.2 · 632 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.7 · 466 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 557 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 7,242 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.3 (0.14 to 0.46) · 17,585 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.05 to 0.37) · 18,947 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.16 (1.96 to 4.35) · 7,265 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.33 (0.44 to 2.22) · 4,100 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.05 (6.38 to 11.73) · 4,115 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.74 (3.02 to 6.45) · 4,325 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.48 to 2.84) · 1,745 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 156 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections1.072No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.406No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.337No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.5 · 400 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.1 · 1,055 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-18 · 288 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-31.6 · 752 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-10.7 · 504 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.4 · 668 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.2 to 6.4) · 1,413 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.4 (9.9 to 13) · 1,413 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.6 · 162 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.9 · 232 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.5 · 215 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits10.9 (8.8 to 13.5) · 4,301 casesNo differentJan 2022 – Dec 2024

What patients said (1,643 patients answered, 22% of those asked)

Patient survey stars by topic at Vanderbilt University Medical Center
Cleanliness3
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Vanderbilt University Medical Center
Room was "always" clean66%
Nurses "always" communicated well79%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand76%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$49,364

Medicare paid this office $49,364 for 412 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)128$11,094$67
Short return visit (20+ min)147$9,546$44
Pathology examination of tissue using a microscope, intermediate complexity189$7,848$28
Destruction of precancer skin growth, 1 growth98$4,401$34
Destruction of skin growth, 1-14 growths64$3,289$46
See all 13 services
Every Original Medicare service billed
Return visit (30+ min)128$11,094$67
Short return visit (20+ min)147$9,546$44
Pathology examination of tissue using a microscope, intermediate complexity189$7,848$28
Destruction of precancer skin growth, 1 growth98$4,401$34
Destruction of skin growth, 1-14 growths64$3,289$46
Biopsy of related skin growth, first growth119$3,060$19
Biopsy of related skin growth, each additional growth61$1,696$15
Special stained specimen slides to examine tissue, initial procedure41$1,215$26
Special stained specimen slides to examine tissue, each additional procedure19$1,059$22
Destruction of precancer skin growth, 2-14 growths74$619$1
Special stained specimen slides to identify organisms including interpretation and report12$288$18
Punch biopsy, first skin growth11$287$24
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's21$284$13

Procedures Medicare counted

Procedure volume Medicare published
Removal of skin lesions147More than 78% of doctors who do this
Skin biopsy154More than 81% of doctors who do this

Procedures year by year

Procedures billed to Original Medicare by year
Procedure2021202220232024
Destruction of precancer skin growth, 2-14 growths–90428424
Biopsy of related skin growth, first growth–24123159
Destruction of precancer skin growth, 1 growth–37135129
Biopsy of related skin growth, each additional growth––99115
Destruction of skin growth, 1-14 growths–158272
Punch biopsy, first skin growth––3012

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

412 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 10% · Women 51% · Also on Medicaid 3% · Health risk score 1.35. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.

Conditions among them: High blood pressure 69% · Chronic kidney disease 28% · Coronary heart disease 26% · Diabetes 24% · Depression 22% · Cancer 20% · Atrial fibrillation 18% · Heart failure 12% · COPD 8% · Stroke 6% · Dementia 5%.

The office billed $318,842, Medicare allowed $66,594 and paid $49,364; for 1,816 services of 36 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244121,816741.35$318,842$49,364
20232421,374721.83$254,688$40,161
202299317721.24$79,010$13,247
20212370711.81$31,260$5,607

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Return visit (30+ min)116$11,536$68
Short return visit (20+ min)121$7,567$44
Destruction of precancer skin growth, 1 growth96$4,383$32
Destruction of skin growth, 1-14 growths61$3,674$45
Biopsy of related skin growth, first growth100$2,325$19
New patient visit (45+ min)20$1,664$83
Biopsy of related skin growth, each additional growth51$1,559$16
New patient visit (30+ min)20$988$49
Punch biopsy, first skin growth28$844$28
Destruction of precancer skin growth, 2-14 growths77$609$1

2022: 8 services

Original Medicare services billed in 2022
Return visit (30+ min)26$3,021$92
New patient visit (45+ min)28$3,011$108
Destruction of precancer skin growth, 1 growth36$1,369$37
Short return visit (20+ min)22$1,291$54
New patient visit (30+ min)20$1,117$56
Destruction of skin growth, 1-14 growths15$716$48
Biopsy of related skin growth, first growth23$629$26
Destruction of precancer skin growth, 2-14 growths25$212$2

Medicaid work

$25,933 in 2022

Medicaid paid $25,933 for 242 billed services this clinician did in 2022, up to 32 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2022
Clinic visit/encounter, all-inclusive81$25,801
Short return visit (20+ min)88$132
Service73$0
Medicaid work by year
2022242332$25,933
2021338340$40,224
201945123$0
See the largest Medicaid services in earlier years

2021

Largest Medicaid services in 2021
Clinic visit/encounter, all-inclusive127$39,939
Short return visit (20+ min)105$284
Service106$0

2019

Largest Medicaid services in 2019
Short return visit (20+ min)45$0

Drugs they prescribed that Part D paid

$675,393

Pharmacies billed $675,393 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 503) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.

409 generic and 94 brand-name prescriptions · $675,393 in drug cost · 14 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Dupixent49$297,629$6,074
Opzelura15$63,252$4,217
Fluorouracil27$1,924$71
Ketoconazole46$851$19
Fluocinolone Acetonide18$675$37
See all 15 drugs
Every Part D drug this clinician prescribed
Dupixent49$297,629$6,074
Opzelura15$63,252$4,217
Fluorouracil27$1,924$71
Ketoconazole46$851$19
Fluocinolone Acetonide18$675$37
Imiquimod14$626$45
Ciclopirox21$479$23
Hydrocortisone29$460$16
Metronidazole12$435$36
Clindamycin Phosphate15$430$29
Minoxidil25$295$12
Triamcinolone Acetonide27$292$11
Mupirocin26$199$8
Gabapentin14$143$10
Hydroxychloroquine Sulfate11$118$11

Year by year

Part D prescribing by year
20245031530% (0)19%$675,393
2023423139None22%$650,424
2022254960% (0)7%$72,870
202177300% (0)None$2,956
20175430NoneNone$2,094
20163422NoneNone$560

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 14 drugs

Part D drugs prescribed in 2023
Dupixent54$322,051$5,964
Opzelura14$61,343$4,382
Clobetasol Propionate19$1,379$73
Ketoconazole49$1,140$23
Fluorouracil12$1,008$84
Metronidazole14$931$66
Clindamycin Phosphate14$620$44
Triamcinolone Acetonide40$448$11
Hydrocortisone38$322$8
Hydroxychloroquine Sulfate12$182$15
Prednisone28$175$6
Mupirocin19$166$9
Spironolactone14$114$8
Gabapentin11$91$8

2022: 6 drugs

Part D drugs prescribed in 2022
Fluorouracil14$1,853$132
Fluocinonide19$1,722$91
Triamcinolone Acetonide51$1,124$22
Clobetasol Propionate11$628$57
Ketoconazole23$512$22
Hydrocortisone12$126$11

2021: 1 drug

Part D drugs prescribed in 2021
Triamcinolone Acetonide20$446$22

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
97.1 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1073963997
Licence
CA A152474, TN 66159California A152474: Delinquent · expires 2023-11-30Tennessee 66159: Licensed
Trained
Baylor College of Medicine, 2016 · 10 years ago
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ND0900X (207ND0900X)
Mailing address
3841 Green Hills Village Dr, Nashville, TN, 37215
NPI first listed
2016-06-21
NPI last updated
2025-12-15
NPI record certified
2025-12-15

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 330 Mount Auburn St, Cambridge, MA, 02138 · 995 Potrero Ave Bldg 90, San Francisco, CA, 94110

This office lists an electronic records connection.